Sertraline for social phobia: a double-blind, placebo-controlled crossover study. 1995

D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
Foundation for Health, Research and Education, Madison, WI 53717, USA.

OBJECTIVE The authors examined the efficacy of sertraline in the treatment of social phobia. METHODS In a double-blind crossover study, 12 outpatients were randomly assigned to 10 weeks of sertraline (50-200 mg/day, flexible dosing) and 10 weeks of placebo. RESULTS A statistically significant improvement in scores on the Liebowitz Social Anxiety Scale was found with sertraline but not with placebo. There was no significant difference between scores obtained with computer- and clinician-administered versions of the Liebowitz Social Anxiety Scale, and the majority of patients preferred to be interviewed by the computer. CONCLUSIONS Sertraline seems a safe and effective treatment for social phobia, and computer administration may be a preferable mode of assessment with socially phobic patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010698 Phobic Disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable. Claustrophobia,Neuroses, Phobic,Phobia, School,Phobias,Phobic Neuroses,Scolionophobia,Disorder, Phobic,Phobia,Phobic Disorder,School Phobia
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003936 Diagnosis, Computer-Assisted Application of computer programs designed to assist the physician in solving a diagnostic problem. Computer-Assisted Diagnosis,Computer Assisted Diagnosis,Computer-Assisted Diagnoses,Diagnoses, Computer-Assisted,Diagnosis, Computer Assisted
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
February 2001, The American journal of psychiatry,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
October 2001, The American journal of psychiatry,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
May 1999, The American journal of psychiatry,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
April 1997, The Journal of clinical psychiatry,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
June 1994, Psychopharmacology,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
January 1999, Archives of family medicine,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
January 1989, Psychopharmacology bulletin,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
December 2005, Journal of clinical psychopharmacology,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
August 1999, The British journal of psychiatry : the journal of mental science,
D J Katzelnick, and K A Kobak, and J H Greist, and J W Jefferson, and J M Mantle, and R C Serlin
April 2000, Psychopharmacology,
Copied contents to your clipboard!